Trial Profile
A Multi-center, Phase III, Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Antineoplastics
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms MACRO; WUJING
- Sponsors Roche
- 18 Dec 2013 New trial record